Phase I Trial of Chemoradiation With Capecitabine and Vorinostat in Pancreatic Cancer
Phase of Trial: Phase I
Latest Information Update: 16 Jun 2015
At a glance
- Drugs Vorinostat (Primary) ; Capecitabine
- Indications Biliary cancer; Pancreatic cancer
- Focus Adverse reactions
- 12 Jun 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 16 May 2013 Planned end date changed from 1 May 2015 to 1 Mar 2018 as reported by ClinicalTrials.gov.
- 16 May 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History